B. ARMAĞAN Et Al. , "Antibodies to Both Ro52 and Ro60 for Identifying Sjogren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies," ARTHRITIS CARE & RESEARCH , vol.74, no.9, pp.1559-1565, 2022
ARMAĞAN, B. Et Al. 2022. Antibodies to Both Ro52 and Ro60 for Identifying Sjogren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies. ARTHRITIS CARE & RESEARCH , vol.74, no.9 , 1559-1565.
ARMAĞAN, B., Robinson, S. A., Bazoberry, A., Perin, J., Grader-Beck, T., Akpek, E. K., ... Kim, J.(2022). Antibodies to Both Ro52 and Ro60 for Identifying Sjogren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies. ARTHRITIS CARE & RESEARCH , vol.74, no.9, 1559-1565.
ARMAĞAN, BERKAN Et Al. "Antibodies to Both Ro52 and Ro60 for Identifying Sjogren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies," ARTHRITIS CARE & RESEARCH , vol.74, no.9, 1559-1565, 2022
ARMAĞAN, BERKAN Et Al. "Antibodies to Both Ro52 and Ro60 for Identifying Sjogren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies." ARTHRITIS CARE & RESEARCH , vol.74, no.9, pp.1559-1565, 2022
ARMAĞAN, B. Et Al. (2022) . "Antibodies to Both Ro52 and Ro60 for Identifying Sjogren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies." ARTHRITIS CARE & RESEARCH , vol.74, no.9, pp.1559-1565.
@article{article, author={BERKAN ARMAĞAN Et Al. }, title={Antibodies to Both Ro52 and Ro60 for Identifying Sjogren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies}, journal={ARTHRITIS CARE & RESEARCH}, year=2022, pages={1559-1565} }